MedTrace Logo

Ayre's Sensory-Motor Integration Exercises and Sensory Modulation And Motor Skills In Children With ASD

NCT07576907 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2026-05-08

No results posted yet for this study

Summary

This study will adopt a quasi-experimental design, featuring assessments before and after the intervention for both the experimental and control groups. We plan to recruit thirty children aged 9 to 11 years, all diagnosed with ASD, from a local clinical setting. Participants will be randomly assigned to either a treatment group, which will undergo 12 sessions of sensory-motor integration exercises, or a control group that will receive standard care. Each session will include structured sensory-based activities based on Ayres Sensory Integration® principles.

Conditions

  • Motor Skills Disorders
  • Sensory Processing Disorder

Interventions

OTHER

Ayre's Sensory-Motor Integration Exercises

Ayres' Sensory-Motor Integration Exercises are play-based therapeutic activities designed to improve how children process sensory information. They target tactile, proprioceptive, and vestibular systems through tasks like swinging, balancing, crawling, and object manipulation. Sessions are individualized and child-centered to promote adaptive responses, motor coordination, and functional skills.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Eram Aslam, MS · Riphah International University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
9 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2026-07-01
Completion
2026-07-01

Countries

  • Pakistan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07576907 on ClinicalTrials.gov